Standardization and Quality Control of the Herbal Medicine Mist Nibima, Employed to Treat Malaria and COVID-19, Using Physicochemical and Organoleptic Parameters and Quantification of Chemical Markers via UHPLC-MS/MS

Table 5

Names of compounds/active ingredients identified in Mist Nibima and their RTs, peak areas, percentage compositions, and concentrations in Mist Nibima.

Peak	Proposed compound	RT (min)	Area	Composition in Mist Nibima (%) (µg/mL) (mg/330 mL bottle)
1	Quindoline	1.352	2070555301.3	20.78	10.42 ± 0.143	3.44 ± 0.047
2	Methyl cryptolepinoate	1.577	3697465123.3	37.10	18.64 ± 0.255	6.15 ± 0.084
3	Hydroxycryptolepine	6.321	339811726.26	3.41	1.70 ± 0.023	0.56 ± 0.011
4	Cryptolepine	9.835	3344237823.9	33.56	16.85 ± 0.231	5.56 ± 0.076
5	11-Isopropylcryptolepine	10.962	514102921.06	5.16	2.56 ± 0.034	0.85 ± 0.007